DK1224222T3 - Chemokinreceptor - Google Patents

Chemokinreceptor

Info

Publication number
DK1224222T3
DK1224222T3 DK00973455.9T DK00973455T DK1224222T3 DK 1224222 T3 DK1224222 T3 DK 1224222T3 DK 00973455 T DK00973455 T DK 00973455T DK 1224222 T3 DK1224222 T3 DK 1224222T3
Authority
DK
Denmark
Prior art keywords
chemokine receptor
methods
expression
receptor
modulate
Prior art date
Application number
DK00973455.9T
Other languages
English (en)
Inventor
Jennifa Gosling
Michael Hanley
Zhenhua Miao
Thomas J Schall
Daniel J Dairaghi
Original Assignee
Chemocentryx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemocentryx Inc filed Critical Chemocentryx Inc
Application granted granted Critical
Publication of DK1224222T3 publication Critical patent/DK1224222T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
DK00973455.9T 1999-10-12 2000-10-10 Chemokinreceptor DK1224222T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US15901599P 1999-10-12 1999-10-12
US15921099P 1999-10-13 1999-10-13
US17297999P 1999-12-20 1999-12-20
US17338999P 1999-12-28 1999-12-28
US18662600P 2000-03-03 2000-03-03
PCT/US2000/028067 WO2001027146A2 (en) 1999-10-12 2000-10-10 Chemokine receptor

Publications (1)

Publication Number Publication Date
DK1224222T3 true DK1224222T3 (da) 2010-05-17

Family

ID=27538581

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00973455.9T DK1224222T3 (da) 1999-10-12 2000-10-10 Chemokinreceptor

Country Status (9)

Country Link
EP (1) EP1224222B1 (da)
JP (1) JP4754143B2 (da)
AT (1) ATE457317T1 (da)
AU (1) AU783776B2 (da)
CA (1) CA2387018C (da)
DE (1) DE60043823D1 (da)
DK (1) DK1224222T3 (da)
ES (1) ES2339326T3 (da)
WO (1) WO2001027146A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835547B1 (en) 1999-10-12 2004-12-28 Chemocentryx, Inc. Methods for identifying modulators of CCX CKR activity
USRE39849E1 (en) 1999-10-12 2007-09-18 Chemocentryx, Inc. Methods for identifying modulators of CCX CKR activity
WO2001066598A2 (en) * 2000-03-03 2001-09-13 Icos Corporation Chemoattractant receptor characterization and cell selection materials and methods and chemokine receptor ccr11 materials and methods
WO2004019046A1 (en) * 2002-08-19 2004-03-04 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 6(cxcr6)
US20050176073A1 (en) * 2004-02-06 2005-08-11 Chemocentryx, Inc. Cell proliferation associated with CCX CKR expression
US20050208595A1 (en) * 2004-03-19 2005-09-22 Brown Arthur M High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
CN100342017C (zh) * 2004-05-10 2007-10-10 中国医学科学院肿瘤医院肿瘤研究所 基因重组趋化抗原疫苗
US9718887B2 (en) 2012-09-06 2017-08-01 Adelaide Research & Innovation Pty Ltd Methods and products for preventing and/or treating metastatic cancer

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US5055556A (en) 1981-10-06 1991-10-08 The Board Of Trustees Of The Leland Stanford Jr. Univ. Fluorescent conjugates for analysis of molecules and cells
US5093245A (en) 1988-01-26 1992-03-03 Applied Biosystems Labeling by simultaneous ligation and restriction
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
JPH02307059A (ja) 1989-05-23 1990-12-20 Seiko Instr Inc 反応容器
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5714350A (en) 1992-03-09 1998-02-03 Protein Design Labs, Inc. Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
GB2273932A (en) 1992-11-24 1994-07-06 Stiefel Laboratories Stable oligonucleotides
US5514555A (en) 1993-03-12 1996-05-07 Center For Blood Research, Inc. Assays and therapeutic methods based on lymphocyte chemoattractants
US5563762A (en) 1994-11-28 1996-10-08 Northern Telecom Limited Capacitor for an integrated circuit and method of formation thereof, and a method of adding on-chip capacitors to an integrated circuit
EP0899332A3 (en) * 1997-08-15 2000-07-05 Smithkline Beecham Corporation The G-protein coupled receptor HFIAO41
US5932445A (en) * 1997-11-07 1999-08-03 Incyte Pharmaceuticals, Inc. Signal peptide-containing proteins
JP2002241399A (ja) * 1997-12-24 2002-08-28 Asahi Kasei Corp ７回膜貫通型受容体蛋白質ｅｔ２４０
WO1999052945A2 (en) * 1998-04-16 1999-10-21 Millenium Pharmaceuticals, Inc. NOVEL MOLECULES OF THE BGCKr-RELATED PROTEIN FAMILY AND USES THEREOF
AU1242800A (en) * 1998-11-04 2000-05-22 Chiron Corporation Isolated vshk-1 receptor polypeptides and methods of use thereof
US6620615B1 (en) * 1999-04-23 2003-09-16 Curagen Corporation G-protein coupled receptor—encoding nucleic acids
US9715915B2 (en) 2014-10-30 2017-07-25 Samsung Electronics Co., Ltd. Magneto-resistive devices including a free layer having different magnetic properties during operations

Also Published As

Publication number Publication date
EP1224222B1 (en) 2010-02-10
ATE457317T1 (de) 2010-02-15
JP4754143B2 (ja) 2011-08-24
JP2003512028A (ja) 2003-04-02
AU1195901A (en) 2001-04-23
AU783776B2 (en) 2005-12-01
WO2001027146A3 (en) 2001-11-22
DE60043823D1 (en) 2010-03-25
ES2339326T3 (es) 2010-05-19
CA2387018A1 (en) 2001-04-19
CA2387018C (en) 2008-02-12
WO2001027146A2 (en) 2001-04-19
WO2001027146A9 (en) 2002-05-10
EP1224222A2 (en) 2002-07-24

Similar Documents

Publication Publication Date Title
DE69918946D1 (de) Rezeptoren für il-18
TR199600001A2 (tr) Estrojen agonistleri / antagonistleri.
DE69901714T2 (de) Elektrochemischer affinitätsassay
IL170669A0 (en) Anaplastic lymphoma kinase assay, reagents and compositions thereof
DE69709561T2 (de) Östrogen-Rezeptor
WO2001042288A3 (en) G-protein coupled receptors
ATE416173T1 (de) 1-(3 -heteroarylpropyl- oder -prop -2-enyl) -4- benzylpiperidine als nmda-rezeptor-antagonisten
WO2001057085A3 (en) G-protein coupled receptors
WO2001087937A3 (en) G-protein coupled receptors
DK1224222T3 (da) Chemokinreceptor
EP2093293A3 (en) G-Protein coupled receptors
SE9804175D0 (sv) New assay
ATE273389T1 (de) Rezeptor des y-y5 neuropeptids
WO2001072836A3 (en) G-protein coupled receptors
WO2002026825A3 (en) G-protein coupled receptors
WO2001066742A3 (en) G-protein coupled receptors
WO2000065054A3 (en) Human membrane-associated proteins
ATE393238T1 (de) Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sind
NO20013748L (no) Ny analyse
BR9808514A (pt) Proteìnas quiméricas do ligante flt3
WO1999038975A3 (en) Polynucleotide and polypeptide sequences associated with cns depressant sensitivity and methods of use thereof
DE60236643D1 (de) Opiatrezeptoren
MX9604079A (es) Ensayo homogeneo de sondas genicas con un receptor dirigido contra el marcador.
WO2002079448A3 (en) G-protein coupled receptors
WO2002029061A3 (en) G-protein coupled receptors